- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin in acute myocardial infarction: the EMMY trial
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 43, Issue 41, Pages 4421-4432
Publisher
Oxford University Press (OUP)
Online
2022-08-26
DOI
10.1093/eurheartj/ehac494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- (2022) Paul A. Heidenreich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
- (2022) Adriaan A. Voors et al. NATURE MEDICINE
- Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved
- (2022) James L. Januzzi et al. JACC-Heart Failure
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
- (2021) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry
- (2021) Oscar Otero-García et al. European Heart Journal-Acute Cardiovascular Care
- Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
- (2021) Gloria M. Gager et al. Frontiers in Cardiovascular Medicine
- Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction
- (2021) Marie-Sophie L.Y. de Koning et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
- (2021) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ketones can become the major fuel source for the heart but do not increase cardiac efficiency
- (2020) Kim L Ho et al. CARDIOVASCULAR RESEARCH
- Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction
- (2020) Wanda Y. Wu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial
- (2020) Wataru Shimizu et al. Cardiovascular Diabetology
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF
- (2020) Yan Deng et al. CIRCULATION RESEARCH
- Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure
- (2020) Salva R. Yurista et al. Circulation-Heart Failure
- Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction
- (2019) Jun-Won Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
- (2019) Roni Nielsen et al. CIRCULATION
- The anti-inflammatory effects of SGLT inhibitors
- (2019) Álvaro García-Ropero et al. Aging-US
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial
- (2019) Norbert J Tripolt et al. AMERICAN HEART JOURNAL
- Left ventricular ejection fraction reassessment post–myocardial infarction: Current clinical practice and determinants of adverse remodeling
- (2018) Derek S. Chew et al. AMERICAN HEART JOURNAL
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study
- (2017) A Olivier et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Khadijah Breathett et al. Circulation-Heart Failure
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- robustlmm: An R Package for Robust Estimation of Linear Mixed-Effects Models
- (2016) Manuel Koller Journal of Statistical Software
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome
- (2009) Kai M. Eggers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now